Chapter 33 The history of movement disorders

Handbook of Clinical Neurology

Volumn 95, Issue C, 2009, Pages 501-546

  Lanska, Douglas J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL GANGLION; CLASSIFICATION; HISTORY; HUMAN; MOTOR DYSFUNCTION; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

BASAL GANGLIA; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; MOVEMENT DISORDERS;

EID: 71749101849     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(08)02133-7     Document Type: Chapter

References (494)

1. Adams R.D., and Foley J.M. The neurological changes in the more common types of severe liver disease. Trans Am Neurol Assoc 74 (1949) 217-219
2. Adams R.D., and Foley J.M. The neurological disorders associated with liver disease. Res Publ Assoc Res Nerv Ment Dis 32 (1953) 198-237
3. Adams R.D., and van Bogaert. Striato-nigral degeneration. J Neuropathol Exp Neurol 23 (1964) 584-608
4. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
5. Albin R.L., Aldridge J.W., Young A.B., et al. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Res 491 (1989) 185-188
6. Albin R.L., Young A.B., Penney J.B., et al. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 322 (1990) 1293-1298
7. Albin R.I., Reiner A., Anderson K.D., et al. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 31 (1992) 425-430
8. Alexander G.E., and DeLong M.R. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986) 357-381
9. Altenmüller E. In: J B., and F B. (Eds). Neurological Disorders in Famous Artists (2005), Karger, Basel 179-188
10. Alzheimer A. Über die anatomische Grundlage der Huntingtonischen Chorea und der choreatischen Bewegungen überhaupt. Z Gesamte Neurol Psychiatr 3 (1911) 566-567
11. American College of Medical Genetics/American Society of Human Genetics (ACMG/ASHG) Huntington Disease Genetic Testing Working Group. ACMG/ASHG statement: laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 62 (1998) 1243-1247
12. Anden N.E., Carlsson A., Dahlstr-m A., et al. Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci 3 (1964) 523-530
13. Anden N.E., Dahlström K., Fuxe, et al. Further evidence for the presence of nigro-striatal dopamine neurons in the rat. Am J Anat 116 (1965) 329-333
14. Andermann F., Keene D.L., Andermann E., et al. Startle disease or hyperekplexia: further delineation of the syndrome. Brain 103 (1980) 985-997
15. Andrew S.E., Goldberg Y.P., Kremer B., et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4 (1993) 398-403
16. Arima K., Ueda K., Sunohara N., et al. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol (Berl) 96 (1998) 439-444
17. Ayd Jr. J.L. A survey of drug-induced extrapyramidal reactions. JAMA 75 (1961) 1054-1060
18. Aziz T.Z., Peggs D., Sambrook M.A., et al. Lesions of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 6 (1991) 288-292
19. Barbeau A. The understanding of involuntary movements: an historical approach. J Nerv Ment Dis 127 (1958) 469-489
20. Barbeau A. Dégénérescence plurisystématisée du nevraxe. Syndrome de Steele-Richardson-Olszewski. Union Med Can 94 (1965) 715-718
21. Barbeau A. Parental ascent in the juvenile form of Huntington's chorea. Lancet 2 (1970) 927
22. Barbeau A., Sourkes T.L., and Murphy G.F. Les catécholamines dans la maladie de Parkinson. In: de Ajuriaguerra J. (Ed). Monoamines et Système Nerveux Central (1962), Georg, Genève and Masson, Paris 247-262
23. Barraquer-Bordas L., and Giménez-Roldán S. Idiopathic torsion dystonia as described by Barraquer-Roviralta. Adv Neurol 50 (1988) 665-666
24. Barraquer-Roviralta L. Contribución al estudio de la atetosis. Gac Med Catalana 20 (1897) 385-391
25. Beal M.F., Kowall N.W., Ellison D.W., et al. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 32 (1986) 168-171
26. Beard G.M. Neurasthenia, or nervous exhaustion. Boston Medical and Surgical Journal 80 (1869) 217-221
27. Beard G. Dr. Beard's verbal communication. J Nerv Ment Dis 5 (1878) 525-526
28. Beard G.M. Experiments with the "jumpers" or "jumping Frenchmen" of Maine. J Nerv Ment Dis 7 (1880) 487-490
29. Beard G.M. Experiments with the "jumpers" of Maine. Popul Sci Monthly 18 (1880) 170-178
30. Beard G.M., and Rockwell A.D. A Practical Treatise on the Medical and Surgical Uses of Electricity Including Localized and General Electrolization (1871), William Wood, Philadelphia, PA 452
31. Bearn A.G. Wilson's disease. An inborn error of metabolism with multiple manifestations. Am J Med 22 (1957) 747-757
32. Bearn A.G. A genetical analysis of 30 families with Wilson's disease (hepatolenticular degeneration). Ann Hum Genet 24 (1960) 33-43
33. Bearn A.G., and Kunkel H.G. Biochemical abnormalities in Wilson's disease. J Clin Invest 31 (1952) 616
34. Bell C. The Nervous System of the Human Body (1830), Longmans, London 221
35. Benabid A.L., Pollak P., Louveau A., et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl Neurophysiol 50 (1987) 344-346
36. Benabid A.L., Pollak P., Gervason C., et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337 (1991) 403-406
37. Benabid A.L., Pollak P., Gross C., et al. Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 62 (1994) 76-84
38. Benazzouz A., Gross C., Feger J., et al. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 5 (1993) 382-389
39. Berciano J., Combarros O., Polo J.M., et al. An early description of striatonigral degeneration. J Neurol 246 (1999) 462-466
40. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 (1990) 1436-1438
41. Bergman H., Wichmann T., Karmon B., et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J Neurophysiol 72 (1994) 507-520
42. Bertler A., and Rosengren E. Occurrence and distribution of catechol amines in brain. Acta Physiol Scand 47 (1959) 350-361
43. Birkmayer W., and Hornykiewicz O. Der L-3,4-Dioxyphenylalanin (=DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73 (1961) 787-788 [English translation in Parkinsonism Rel Dis 1998; 4: 59-60.]
44. Blackwood W.R.D. Mechanical writing in the prevention and cure of writers' cramp and allied disorders. Medical Register (Philadelphia) 5 (1889) 365-366
45. Blocq P., and Marinescu G. Sur un cas de tremblement parkinsonien hémiplégique symptomatique d'une tuneur du peduncle cerebral. Comptes Rendus Hebdomadaires des Séances et Mémoires de la Société de Biologie 5 (1893) 105-111
46. Bouteille E.M. Traité de la Chorée, ou Danse de St (1810), Guy, Vincard, Paris
47. Bramwell B. Familial cirrhosis of the liver: four cases of acute fatal cirrhosis in the same family, the patients being respectively nine, ten, fourteen and fourteen years of age: suggested relationship to Wilson's progressive degeneration of the lenticular nucleus. Edinburgh Med J 17 (1916) 90-99
48. Brandt J., Bylsma F.W., Gross R., et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46 (1996) 527-531
49. Brewer G.J., Hill G.M., Prasad A.S., et al. Oral zinc therapy for Wilson's disease. Ann Intern Med 99 (1983) 314-320
50. Brewer G.J., Dick R.D., Johnson V., et al. Treatment of Wilson's disease with zinc. XV. Long-term follow-up studies. J Lab Clin Med 132 (1998) 264-278
51. Bright R. Reports of Medical Cases Selected with a View of Illustrating the Symptoms and Cure of Disease by Reference to Morbid Anatomy (1831), Longman, London
52. Brin M.F., Fahn S., Moskowitz C., et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 2 (1987) 237-254
53. Brissaud E. Leçons sur les Maladies du Système Nerveux (1895), Masson, Paris
54. Broadbent W.H. On the pathology of chorea. Br Med J 86 (1869) 345-347 369-371
55. Browning W. Rev. Charles Oscar Waters, M.D. Neurographs 1 (1908) 137-144
56. Browning W. Irving Whitall Lyon, M.D. Neurographs 1 (1908) 147-149
57. Brusa A., Stoehr R., and Pramstaller P.P. Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism. Mov Disord 19 (2004) 247-252
58. Bull P.C., Thomas G.R., Rommens J.M., et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5 (1993) 327-337
59. Burke R.E., Fahn S., and Marsden C.D. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexphenidyl. Neurology 36 (1986) 160-164
60. Burns R.S., Chiueh C.C., Markey S.P., et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80 (1983) 4546-4550
61. Burr C.W. Local spasms. Occupation spasms. In: Dercum F.X. (Ed). A Text-book on Nervous Diseases by American Authors (1895), Lea Brothers and Co., Philadelphia, PA 275-279
62. Butler I.J., Koslow S.H., Seifert Jr. W.E., et al. Biogenic amine metabolism in Tourette syndrome. Ann Neurol 6 (1979) 37-39
63. Buzzard T. Two cases of impaired writing power treated successfully by electricity. Practitioner 9 (1872) 65-74
64. Calne D.B., Reid J.L., Vakil S.D., et al. Idiopathic parkinsonism treated with extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J 3 (1971) 729-732
65. Calne D.B., Teychenne P.F., Claveria L.E., et al. Bromocriptine in parkinsonism. Br Med J 4 (1974) 442-444
66. Campion D., Martin C., Heilig R., et al. The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease. Genomics 26 (1995) 254-257
67. Canfield R.M., and Putnam J.J. A case of acute hemiplegic chorea; with autopsy and remarks. Boston Medical and Surgical Journal 111 (1884) 220-223
68. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev 11 (1959) 490-493
69. Carlsson A. A half-century of neurotransmitter research: impact on neurology and psychiatry. In: Jörnvall H. (Ed). Nobel Lectures, Physiology or Medicine 1996-2000 (2003), World Scientific, Singapore 303-322
70. Carlsson A., Lindqvist M., and Magnusson T. 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180 (1957) 1200
71. Carpenter M.B. Athetosis and the basal ganglia: Review of the literature and study of forty-two cases. Arch Neurol Psychiatry 63 (1950) 875-901
72. Carpenter M.B. Ballism associated with partial destruction of the subthalamic nucleus of Luys. Neurology 5 (1955) 479-489
73. Carpenter M.B., and Carpenter C.S. Analysis of somatotopic relations of the corpus Luysi in man and monkey: relation between the site of dyskinesia and distribution of lesions within the subthalamic nucleus. J Comp Neurol 95 (1951) 349-370
74. Carpenter M.B., Whittier J.R., and Mettler F.A. Analysis of choreoid hyperkinesias in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesias resulting from lesions in the subthalamic nucleus of Luys. J Comp Neurol 92 (1950) 293-331
75. Charcot J.-M. On paralysis agitans. In: Sigerson G. (Ed). Lectures on Diseases of the Nervous System: Delivered at La Salpêtrière (1877), New Sydenham Society, London 129-156 Vol. 1
76. Charcot J.-M. On athetosis. In: Sigerson G. (Ed). Lectures on Diseases of the Nervous System: Delivered at La Salpêtrière Vol. 2 (1881), New Sydenham Society, London 390-394
77. Charcot J.-M. Tremblements et mouvements chroréiformes. Chorée rhythmée. Leçons sur les Maladies du Système Nerveux Faites à la Salpêtrière (1887), A. Delahaye et E. Lecrosnie, Paris 209-225
78. Charcot J.-M. Gilles de la Tourette syndrome: a child with convulsive tic and coprolalia: December 13, 1887. In: Goetz C.G. (Ed). Charcot: The Clinician: The Tuesday Lessons: Excerpts from Nine Case Presentations on General Neurology Delivered at the Salpêtrière Hospital in 1887-88 (1887/1987), Raven Press, New York 56-70
79. Charcot J.-M. Tremors and choreiform movements - rhythmical chorea. In: Savill T. (Ed). Clinical Lectures on Diseases of the Nervous System: Delivered at the Infirmary of La Salpêtrière Vol. 3 (1889), New Sydenham Society, London 183-197
80. Charcot J.-M., and Vulpian A. De la paralysie agitante. Gazette Hebdomadaire de Médecine et de Chirurgie 8 (1861) 765-767 816-820, and 1861; 9: 54-59
81. Chen X., de Silva H.A., Pettenati M.J., et al. The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis. Genomics 26 (1995) 425-427
82. Chien C.P., DiMascio D.I., and DiMascio A. Drug-induced extra-pyramidal symptoms and their relations to clinical efficacy. Am J Psychiatry 123 (1967) 1490-1498
83. Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. In: Frängsmyr T. (Ed). Les Prix Nobel. The Nobel Prizes 2004 (2005), Nobel Foundation, Stockholm 151-175
84. Coburn A.F. The Factor of Infection in the Rheumatic State (1931), Williams and Wilkins, Baltimore, MD
85. Coburn A.F., and Moore L.V. The prophylactic use of sulfonamide in streptococcal respiratory infections, with special reference to rheumatic fever. J Clin Invest 18 (1939) 147-155
86. Cohen D.J., Shaywitz B.A., Young J.G., et al. Central biogenic amine metabolism in children with syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry 18 (1979) 320-341
87. Conn H.O. Asterixis in non-hepatic disorders. Am J Med 29 (1960) 647-664
88. Corbin K.B. Trihexyphenyl: evaluation of a new agent in the treatment of Parkinson's disease. JAMA 141 (1949) 373-381
89. Correns C.G. Mendel's Regel über das Verhalten der Nachkommenschaft der Rassenbastarde. Berichte der Deutschen Botanischen Gesellschaft 18 (1900) 158-168
90. Corrodi H., Fuxe J., Hökfelt T., et al. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol 25 (1973) 409-412
91. Cotzias G.C., Van Woert M.H., and Schiffer L.M. Aromatic acids and modification of parkinsonism. N Engl J Med 276 (1967) 374-379
92. Cotzias G.C., Papavasiliou P.S., and Gellene R. Modification of parkinsonism - chronic treatment with L-dopa. N Engl J Med 280 (1969) 337-345
93. Cotzias G.C., Papavasiliou P.S., Fehling C., et al. Similarities between neurologic effects of DOPA and of apomorphine. N Engl J Med 282 (1970) 31-33
94. Cotzias G.C., Papavasiliou P.S., Tolosa E.S., et al. Treatment of Parkinson disease with apomorphines: possible role of growth hormone. N Engl J Med 294 (1976) 567-572
95. Coyle J.T., and Schwarcz R. Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea. Nature 263 (1976) 244-246
96. Creutzfeldt H.G. Über eine eigenartige herdomige Erkrankung des Zentralnervensystems. Z Gesamte Neurol Psychiatr 57 (1920) 1-18
97. Critchley M. Observations on essential (heredofamilial) tremor. Brain 72 (1949) 113-139
98. Crossman A.R. Neural mechanism in disorders of movement. Comp Biochem Physiol A 93 (1989) 141-149
99. Cumings J.N. The copper and iron content of brain and liver in the normal and in hepatolenticular degeneration. Brain 71 (1948) 410-415
100. Cumings J.N. The effects of BAL in hepatolenticular degeneration. Brain 74 (1951) 10-22
101. Dale R.C., Church A.J., Surtees R.A., et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 127 (2004) 21-33
102. Dana C.L. Hereditary tremor: a hitherto undescribed form of motor neurosis. Am J Med Sci 94 (1887) 386-393
103. Davies S.W., Turmaine M., Cozens B.A., et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
104. Davis Jr. C.H., and Kunkle E.C. Benign essential (heredofamilial) tremor. Arch Intern Med 87 (1951) 808-816
105. Davis G.C., Williams A.C., Markey S.P., et al. Chronic parkinsonism secondary to intravenous injections of meperidine analogues. Psychiatry Res 1 (1979) 249-254
106. Dawbarn D., De Quidt M.E., and Emson P.C. Survival of basal ganglia neuropeptide Y-somatostatin neurons in Huntington's disease. Brain Res 340 (1985) 251-260
107. Dawson J.R. Cellular inclusions in cerebral lesions of epidemic encephalitis (Second report). Arch Neurol Psychiatry 31 (1934) 685-700
108. de la Boë F. (Sylvius). Disputationes medicarum (1663), Van den Bergh, Amstelodami
109. De Vries H. Sur la loi de disjonction des hybrides. C R Acad Sci 130 (1900) 845-847
110. Degwitz R., Frowein R., Kulenkampff C., et al. Über die Wirkungen des L-DOPA beim Menschen und deren Beeinflussung durch Reserpin, Chlorpromazin, Iproniazid und Vitamin B6. Wien Klin Wochenschr 38 (1960) 120-123
111. Dejerine J.J., and Thomas A. L'atrophie olivo-ponto-cérébelleuse 13 (1900), Nouvelle Iconographie de la Salpêtrière, Paris 330-370
112. Dejerine J.J., and Thomas A. Olivopontocerebellar atrophy. In: Rottenberg D.A., and Hochberg F.H. (Eds). Neurological Classics in Modern Translation (1900/1977), Hafner Press, New York 219-251
113. Delay J., Deniker P., and Harl J.M. Utilisation en thérapeutique psychiatrique d'une phénothiazine d'action centrale élective. Ann Med Psychol (Paris) 110 (1952) 112-117
114. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13 (1990) 281-285
115. Dening T.R., and Berrios G.E. Eponymous confusion over Bruno Fleischer. Lancet 335 (1990) 291
116. Denny Brown D., and Porter H. The effects of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med 245 (1951) 917-925
117. Dewey Jr. R.B., and Jankovic J. Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol 46 (1989) 862-867
118. Dickman M.S. Von Economo encephalitis. Arch Neurol 58 (2001) 1696-1698
119. DiFiglia M., Sapp E., Chase K.O., et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
120. Dooling E.C., and Adams R.D. The pathological anatomy of posthemiplegic athetosis. Brain 98 (1975) 29-48
121. Dorshay L.J., and Constable K. Active therapy for parkinsonism. JAMA 140 (1949) 1317
122. Dupont E., Hansen H.J., and Dalby M.A. Treatment of benign essential tremor with propranolol. A controlled clinical trial. Acta Neurol Scand 49 (1973) 75-84
123. Duyao M., Ambrose C., Myers R., et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 4 (1993) 387-392
124. Ehringer H., and Hornykiewicz O. Verteilung von Adrenalin und Dopamin (3-Hydroxytyramin) im Gehim des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Wien Klin Wochenschr 38 (1960) 1236-1239
125. Eldridge R. The torsion dystonias: literature review and genetic and clinical studies. Neurology 20 (1970) 1-78
126. Elston J.S., and Russell R.W. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 290 (1985) 1857-1859
127. Ernst A.M. Relation between action of dopamine and apomorphine and the O-methylated derivatives upon the CNS. Psychopharmacology (Berl) 7 (1965) 391-399
128. Eschner A.A. A graphic study of tremor. J Exp Med 2 (1897) 301-312
129. Fahn S. High-dosage anticholinergic therapy in dystonia. Adv Neurol 37 (1983) 177-188
130. Fahn S. Concept and classification of dystonia. Adv Neurol 50 (1988) 1-8
131. Farrer L.A., Cupples L.A., Kiely D.K., et al. Inverse relationship between age at onset of Huntington disease and paternal age suggests involvement of genetic imprinting. Am J Hum Genet 50 (1992) 528-535
132. Faurbye A., Rasch R.J., Bender Petersen P., et al. Neurological symptoms in pharmacotherapy of psychosis. Acta Psychiatr Scand 40 (1964) 10-27
133. Fehling C. Treatment of Parkinson's syndrome with L-DOPA: a double blind study. Acta Neurol Scand 42 (1966) 367-372
134. Ferrante R.J., Kowall N.W., Beal M.F., et al. Selective sparing of a class of striatal neurons in Huntington's disease. Science 230 (1985) 561-563
135. Ferrante R.J., Kowall N.W., Beal M.F., et al. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46 (1987) 12-27
136. Ferrier D. The Functions of the Brain (1876), Smith, Elder and Company, London
137. Findley L.J., Cleeves L., and Calzettti S. Primidone in essential tremor of the hands and head: a double-blind controlled clinical study. J Neurol Neurosurg Psychiatry 481 (1985) 911-915
138. Flatau E., and Sterling W. Progressiver Torsionspasmus bei Kindern. Z Gesamte Neurol Psychiatr 7 (1911) 586-612
139. Fleischer B. Zwei weitere Fälle von grünlicher Verfärbung der Kornea. Klin Monatsbl Augenheilkd 41 (1903) 335-352
140. Foley P. The L-DOPA story revisited. Further surprises to be expected? The contribution of Isamu Sano to the investigation of Parkinson's disease. J Neural Transm Suppl 60 (2000) 1-20
141. Foley P. Beans, roots and leaves: a brief history of the pharmacological therapy of parkinsonism. Wurzbg Medizinhist Mitt 22 (2003) 215-234
142. Forel A. Untersuchungen über die Haubenregion und ihre oberen Verknupfungen im Gehirne des Menschen und einiger Saügethiere, mit Beiträgen zu den Methoden des Gehirnuntersuchungen. Arch Psychiatr Nervenkr 7 (1877) 182 393-495
143. Forno L.S., Langston J.W., DeLanney L.E., et al. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20 (1986) 449-455
144. Freyhan F.A. Psychomotility and parkinsonism in treatment with neuroleptic drugs. Arch Neurol Psychiatry 78 (1957) 465-472
145. Friedreich N. Über degenerative Atrophie der spinalen Hinterstränge. Virchows Arch Pathol Anat Physiol Klin Med 26: 391-419, 433-459; 27 (1863) 1-26
146. Friedreich N. Neuropathologische Beobachtung beim Paramyoklonus Multiplex. Virchows Arch Pathol Anat Physiol Klin Med 86 (1881) 421-434
147. Fritsch G., and Hitzig E. On the electrical excitability of the cerebrum. In: von Bonin G. (Ed). Some Papers on the Cerebral Cortex (1870/1960), Charles C. Thomas, Springfield, IL 73-96
148. Frucht S., and Fahn S. The clinical spectrum of posthypoxic myoclonus. Mov Disord 15 (2000) 2-7
149. Frydman M., Bonne-Tamir B., Farrer L.A., et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci USA 82 (1985) 1819-1821
150. Furtado S., Suchowersky O., Rewcastle N.B., et al. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 39 (1996) 132-136
151. Galilei G. Letter dated January 7, 1610. In: Drake S. (Ed). Galileo at Work: His Scientific Biography (1610/1978), University of Chicago Press, Chicago, IL 147
152. Giasson B.I., Duda J.E., Murray I.V.J., et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290 (2000) 985-989
153. Gibb W.R.G., Luthert P.J., and Marsden C.D. Corticobasal degeneration. Brain 112 (1989) 1171-1192
154. Gildenberg P.L. The history of surgery for movement disorders. Neurosurg Clin N Am 9 (1998) 283-293
155. Gilles de la Tourette G. Les "sauteurs" du Maine (États-Unis): Par G. Beard. Arch Neurol (Paris) 2 (1881) 146-150
156. Gilles de la Tourette G. Jumping, Latah, Myriachit. Arch Neurol (Paris) 8 (1884) 68-74
157. Gilles de la Tourette G. Étude sur une affection nerveuse caracterisée par l'incoordination motrice accompagnée d'écholalie et de coprolalie. Arch Neurol (Paris) 9 (1885) 19-42 158-200
158. Gilliam T.C., Tanzi R.E., Haines J.L., et al. Localization of the Huntington's disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell 50 (1987) 565-571
159. Gilman A.G. G proteins and regulation of adenylyl cyclase. In: Ringertz N. (Ed). Nobel Lectures, Physiology or Medicine 1991-1995 (1997), World Scientific, Singapore 182-212
160. Glazebrook A.J. Wilson's disease. Edinburgh Med J 52 (1945) 83-87
161. Goetz C.G. Charcot on Parkinson's disease. Mov Disord 1 (1986) 27-32
162. Goetz C.G., and Klawans H.L. Gilles de la Tourette on Tourette syndrome. Adv Neurol 35 (1982) 1-16
163. Goetz C.G., Bonduelle M., and Gelfand T. Charcot: Constructing Neurology (1995), Oxford University Press, New York 113-120
164. Goetz C.G., Chmura T.A., and Lanska D.J. The basal ganglia: part 1 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 152-155
165. Goetz C.G., Chmura T.A., and Lanska D.J. The history of Parkinson's disease: part 2 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 156-161
166. Goetz C.G., Chmura T.A., and Lanska D.J. Seminal figures in the history of movement disorders: Sydenham, Parkinson, and Charcot: part 6 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 537-540
167. Goetz C.G., Chmura T.A., and Lanska D.J. Parkinson-plus syndromes: part 7 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 541-544
168. Goetz C.G., Chmura T.A., and Lanska D.J. History of chorea: part 3 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 331-338
169. Goetz C.G., Chmura T.A., and Lanska D.J. Seminal figures in the history of movement disorders: Gilles de la Tourette, Oppenheim, the Vogts, von Economo, Wilson, and Marsden: part 12 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 940-946
170. Goetz C.G., Chmura T.A., and Lanska D.J. History of dystonia: part 4 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 339-345
171. Goetz C.G., Chmura T.A., and Lanska D.J. History of myoclonus: part 8 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 545-547
172. Goetz C.G., Chmura T.A., and Lanska D.J. History of tic disorders and Gilles de la Tourette syndrome: part 5 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 346-349
173. Goff D.C., Arana G.W., Greenblatt D.J., et al. The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial. J Clin Psychopharmacol 11 (1991) 106-112
174. Golbe L.I., Di Iorio G., Banavita V., et al. A large kindred with autosomal dominant Parkinson's disease. Ann Neurol 27 (1990) 276-282
175. Goldman M.S., Ahlskog J.E., and Kelly P.J. The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 76 (1992) 924-928
176. Goldstein M., Anagoste B., Owen S., et al. The effects of ventromedial segmental lesions on the biosynthesis of catecholamines in the striatum. Life Sci 5 (1966) 2171-2176
177. Gowers W.R. On "athetosis" and post-hemiplegic disorders of movement. Med Chir Trans (1876) 271-326
178. Gowers W.R. A Manual of Diseases of the Nervous System (1888), J. and A. Churchill, London
179. Gowers W.R. On tetanoid chorea and its association with cirrhosis of the liver. Reviews of Neurology and Psychiatry 4 (1906) 249-258
180. Graham J.G., and Oppenheimer D.R. Orthostatic hypotension, and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32 (1969) 28-34
181. Greenfield J.G., and Bosanquet F.D. The brain-stem lesions in parkinsonism. J Neurol Neurosurg Psychiatry 16 (1953) 213-226
182. Greenfield J.G., and Wolfsohn J.M. The pathology of Sydenham's chorea. Lancet 2 (1922) 603-606
183. Groth C.G., Dubois R.S., Corman J., et al. Hepatic transplantation in Wilson disease. Birth Defects Orig Artic Ser 9 (1973) 106-108
184. Grundmann K. Primary torsion dystonia. Arch Neurol 62 (2005) 682-685
185. Guridi J., and Obeso J.A. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 124 (2001) 5-19
186. Gusella J.F., Wexler N.S., Conneally P.M., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306 (1983) 234-238
187. Gusella J., Tanzi R.E., Bader P.I., et al. Deletion of Huntington's disease linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature 318 (1985) 75-78
188. Hall H.C. La Dégénérescence Hepatolenticulare. Maladie de Wilson-pseudosclerose (1921), Masson, Paris
189. Hall R.A., Jackson R.B., and Swain J.M. Neurotoxic reactions resulting from chlorpromazine administration. JAMA 161 (1956) 214-218
190. Hallett M. Early history of myoclonus. Adv Neurol 43 (1986) 7-10
191. Hamada I., and DeLong M.R. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 68 (1992) 1859-1866
192. Hamani C., Saint-Cyr J.A., Fraser J., et al. The subthalamic nucleus in the context of movement disorders. Brain 127 (2003) 4-20
193. Haméleers R., Temel Y., and Visser-Vandewalle V. History of the corpus Luysii: 1865-1995. Arch Neurol 63 (2006) 1340-1342
194. Hammond G.M. Pathological findings in the original case of athetosis. J Nerv Ment Dis 17 (1890) 555
195. Hammond W.A. Athetosis. A Treatise on Diseases of the Nervous System (1871), D. Appleton and Co., New York 654-662
196. Hammond W.A. Miryachit: a newly described disease of the nervous system, and its analogues. New York Medical Journal 39 (1884) 191-192
197. Hammond W.A., and Hammond G.M. Athetosis. A Treatise on Diseases of the Nervous System (1893), D. Appleton and Co., New York 315-325
198. Hamon J., Paraire J., and Velluz J. Remarques sur l'action du 4560 RP sur l'agitation maniaque. Ann Med Psychol (Paris) 110 (1952) 331-335
199. Haškovec L. L'Akathisie. Rev Neurol 9 (1901) 1107-1109
200. Hassler R. Zur Pathologie der Paralysis agitans und des post-encephalitischen Parkinsonismus. Journal für Psychologie und Neurologie 18 (1938) 387-455
201. Hassler R., and Riechert T. Indikationen und Lokalisationsmethode der gezielten Hirnoperationen. Nervenartz 25 (1954) 441-447
202. Haurowitz F. Über eine Anomalie des Kupferstoffwechsels. Hoppe-Seylers Z Physiol Chem 190 (1930) 72-74
203. Hayashi S., Wakabayashi K., Ishikawa A., et al. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 15 (2000) 884-888
204. Heikkila R.L., Manzio L., Cabbat F.S., et al. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311 (1984) 467-469
205. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. In: Frängsmyr T. (Ed). Les Prix Nobel. The Nobel Prizes 2004 (2005), Nobel Foundation, Stockholm 187-200
206. Herz E. Dystonia I. Historical review, analysis of dystonic symptoms and psychologic mechanisms involved. Arch Neurol Psychiatry 51 (1944) 305-318
207. Herz E. Dystonia II. Clinical classification. Arch Neurol Psychiatry 51 (1944) 319-355
208. Herz E. Dystonia III. Pathology and conclusions. Arch Neurol Psychiatry 52 (1944) 20-26
209. Holdorff B. Friedrich Heinrich Lewy (1885-1950) and his work. J Hist Neurosci 11 (2002) 19-28
210. Holmberg C.G., and Laurell C.B. Investigations in serum copper. I. Nature of serum copper and its relation to the iron-binding protein in human serum. Acta Chem Scand 1 (1947) 944-950
211. Holmberg C.G., and Laurell C.B. Investigations in serum copper. II. Isolation of the copper containing protein, and a description of some of its properties. Acta Chem Scand 2 (1948) 550-556
212. Hoogenraad T.U., Koevoet R., and De Ruyter Korver E.G.W.M. Oral zinc sulfate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 18 (1979) 205-211
213. Hoogenraad T.U., Van Hattum J., and Van den Hamer C.J.A. Management of Wilson's disease with zinc sulfate: experience in a series of 27 patients. J Neurol Sci 77 (1987) 137-146
214. Hoogeveen A.T., Willemsen R., Meyer N., et al. Characterization and localization of the Huntington disease gene product. Hum Molec Genet 2 (1993) 2069-2073
215. Hornykiewicz O. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago. Wien Klin Wochenschr 113 (2001) 855-862
216. Howard R., and Ford R. From the jumping Frenchmen of Maine to post-traumatic stress disorder: the startle response in neuropsychiatry. Psychol Med 22 (1992) 695-707
217. Huntington G. On chorea. Medical and Surgical Reporter 26 (1872) 317-321
218. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
219. Husby G., van de Rijn I., Zabriskie J.B., et al. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 144 (1976) 1094-1110
220. Ishikawa A., and Miyatake T. A family with hereditary juvenile dystonia-parkinsonism. Mov Disord 10 (1995) 482-488
221. Itard J.M.G. Mémoire sur quelques fonctions involontaires des appareils de la locomotion, de la préhension et de la voix. Archives Générales de Medecine 8 (1825) 385-407
222. Jackson J.H. Observations on the physiology and pathology of hemi-chorea. In: Taylor J., Holmes G., and Walshe F.M.R. (Eds). John Hughlings Jackson: Selected Writings Vol. 2 (1868/1996), Arts and Boeve, Nijmegen 238-245
223. Jackson J.H. On epilepsies and on the after-effects of epileptic discharges (Todd and Robertson's hypothesis). In: Taylor J., Holmes G., and Walshe F.M.R. (Eds). John Hughlings Jackson: Selected Writings (1876/1996), Arts and Boeve, Nijmegen 135-161 Vol. 1
224. Jager B.V., and King T. Hereditary tremor. Arch Intern Med 95 (1955) 788-793
225. Jakes R., Spillantini M.G., and Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 345 (1994) 27-32
226. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswerten anatomischen Befunden (spastische Pseudosklerose, Encephalomyelopathie mit disseminierten Degenerationsherden). Z Gesamte Neurol Psychiatr 64 (1921) 147-228
227. Jankovic J., Cardoso F., Grossman R.G., et al. Outcomes after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 37 (1995) 680-686
228. Johnson W.G., Hodge S.E., and Duvoisin R. Twin studies and the genetics of Parkinson's disease - a reappraisal. Mov Disord 5 (1990) 187-194
229. Jummani R.H., and Okun M.S. Sydenham chorea. Arch Neurol 58 (2001) 311-313
230. Kann M., Jacobs H., Mohrmann K., et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann Neurol 51 (2002) 621-625
231. Kayser B. Über einen Fall von angeborener grünlicher Verfärbung der Cornea. Klin Monstbl Augenheilkd 40 (1902) 22-25
232. Kebabian J.W., and Calne D.B. Multiple receptor mechanism for dopamine. Nature 227 (1979) 93-96
233. Keppel Hesselink J.M. Evolution of concepts and definitions of Parkinson's disease since 1817. J Hist Neurosci 5 (1996) 200-207
234. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
235. Klawans H.L., Moses III H., Nausieda P.A., et al. Treatment and prognosis of hemiballismus. N Engl J Med 295 (1976) 1348-1350
236. Klawans H.L., Falk D.K., Nausieda P.A., et al. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology 28 (1978) 1064-1068
237. Klempel K. Gilles de la Tourette's symptoms induced by L-dopa. S Afr Med J 48 (1974) 1379
238. Koehler P.J., and Keyser A. Tremor in Latin texts of Dutch physicians: 16th-18th centuries. Mov Disord 12 (1997) 798-806
239. Kopp J.H. Denkwürdigkeiten in der ärztlichen Praxis (1836), Hermann, Frankfurt
240. Krack P. Relics of dancing mania: the dancing procession of Echternach. Neurology 53 (1999) 2169-2172
241. Krack P., Batir A., Van Blercom N., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349 (2003) 1925-1934
242. Kristensen M.O. Progressive supranuclear palsy - 20 years later. Acta Neurol Scand 71 (1985) 177-189
243. Kruisdijk J.J., Koelman J.H., Ongerboer de Visser B.W., et al. Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry 78 (2007) 264-270
244. Kruse W. Persistent muscular restlessness after phenothiazine treatment: report of three cases. Am J Psychiatry 117 (1960) 152-153
245. Kunkle E.C. The "jumpers" of Maine: past history and present status. J Maine Med Assoc 56 (1965) 191-193
246. Kunkle E.C. The "jumpers" of Maine: a reappraisal. Arch Intern Med 119 (1967) 355-358
247. Kurczynski T.W. Hyperekplexia. Arch Neurol 40 (1983) 246-248
248. Kushner H.L., Luzzatti C., and Finger S. A perplexing document in the early history of Gilles de la Tourette syndrome: Melotti's rendition of a "Lecture by Charcot" (including a complete translation from the Italian with commentary). J Hist Neurosci 8 (1999) 5-20
249. Lahti R.A., Roberts R.C., and Tamminga C.A. D2-family receptor distribution in human postmortem tissue: an autoradiographic study. Neuroreport 6 (1995) 2502-2512
250. Laitinen L.V., Bergenheim A.T., and Hariz M.I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76 (1992) 53-61
251. Laitinen L.V., Bergenheim A.T., and Hariz M.I. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg 58 (1992) 14-21
252. Lajonchere C., Nortz M., and Finger S. Gilles de la Tourette and the discovery of Tourette syndrome: includes a translation of his 1884 article. Arch Neurol 53 (1996) 567-574
253. Lance J.W., and Adams R.D. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 86 (1963) 111-136
254. Lance J.W., and Adams R.D. Negative myoclonus in posthypoxic patients: historical note. Mov Disord 16 (2001) 162-163
255. Lang A.E., Sheehy M.P., and Marsden C.D. Anticholinergics in adult-onset focal dystonia. Can J Neurol Sci 9 (1982) 313-319
256. Langston J.W., and Palfreman J. The Case of the Frozen Addicts (1995), Pantheon Books, New York
257. Langston J.W., Ballard P., Tetrud J.W., et al. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
258. Langston J.W., Irwin I., Lanston E.B., et al. Pargyline prevents MPTP-induced parkinsonism in primates. Science 225 (1984) 1480-1482
259. Lanska D.J. 19th-century American contributions to the recording of tremors. Mov Disord 15 (2000) 720-729
260. Lanska D.J. George Huntington (1850-1916) and hereditary chorea. J Hist Neurosci 9 (2000) 76-89
261. Lanska D.J. Characteristics and lasting contributions of 19th-century American neurologists. J Hist Neurosci 10 (2001) 202-216
262. Lanska D.J. Classic articles by 19th-century American neurologists: a critical review. J Hist Neurosci 11 (2002) 156-173
263. Lanska D.J. Limb immobilization for the treatment of focal occupational dystonia [Letter]. Neurology 58 (2002) 991 [Erratum Neurology 2002;58:1579]
264. th-century instruments for writer's cramp [Abstract]. Neurology 58 (2002) A341
265. Lanska D.J., Goetz C.G., and Chmura T.A. Development of instruments for abnormal movements: dynamometers, the dynamograph, and tremor recorders: part 9 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 736-741
266. Lanska D.J., Goetz C.G., and Chmura T.A. Seminal figures in the history of movement disorders: Huntington, Osler, and Hammond: part 11 of the MDS-sponsored History of Movement Disorders Exhibit, Barcelona, Spain, June 2000. Mov Disord 16 (2001) 749-753
267. Lantos P.L. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 57 (1998) 1099-1111
268. Larsson T., and Sjögren T. Essential tremor: a clinical and genetic population study. Acta Psychiatr Scand 26 (1960) 1-176
269. Leavitt S., and Tyler H.R. Studies in asterixis. Part I. Arch Neurol 10 (1964) 360-368
270. Leeflang E.P., Tavare S., Marjoram P., et al. Analysis of germline mutation spectra at the Huntington's disease locus supports a mitotic mutation mechanism. Hum Mol Genet 8 (1999) 173-183
271. Lehmann H.E., and Hanrahan A.E. Chlorpromazine: new inhibiting agent for psychomotor excitement and manic states. AMA Arch Neurol Psychiatry 71 (1954) 227-237
272. Lewis M.J. The neural disorders of writers and artisans. In: Pepper W., and Starr L. (Eds). A System of Practical Medicine (1885-1886), Lea and Brothers, Philadelphia, PA 504-543 Vol. 5
273. Lewy F.H. Zur pathologischen Anatomie der Paralysis agitans. Dtsch Z Nervenheilkd 50 (1913) 50-55
274. Limousin P., Pollak P., Benazzouz A., et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345 (1995) 91-95
275. Limousin P., Krack P., Pollak P., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339 (1998) 1105-1111
276. Limousin P., Speelman J.D., Gielen F., et al. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 66 (1999) 289-296
277. Lindemulder F.G. Familial myoclonia occurring in three successive generations. J Nerv Ment Dis 77 (1933) 489
278. Lloyd K.G., Davidson L., and Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther 195 (1975) 453-464
279. Louis E.D. The shaking palsy, the first forty-five years: a journey through the British literature. Mov Disord 12 (1997) 1068-1072
280. Louis E.D. Etiology of essential tremor: should we be searching for environmental causes. Mov Disord 16 (2001) 822-829
281. Lucking C.B., Durr A., Bonifati V., et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 342 (2000) 1560-1567
282. Lundborg H. Die Progressive Myoklonus-Epilepsie (1903), Almqvist and Wiksell, Uppsala
283. Luys J.B. Recherches sur la Système Nerveux Cerebrospinal: Sa Structure, Ses Fonctions, et Ses Maladies (1865), Baillière, Paris
284. Lyon I.W. Chronic hereditary chorea. American Medical Times 7 (1863) 289-290
285. Ma S., Davis T.L., Blair M.A., et al. Familial essential tremor with apparent autosomal dominant inheritance: should we also consider other inheritance modes. Mov Disord 21 (2006) 1368-1374
286. McCall S., Henry J.M., Reid A.H., et al. Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol 60 (2001) 696-704
287. McGeer E.G., and McGeer P.L. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic acid and kainic acids. Nature 263 (1976) 517-519
288. McGeer P.L., and Zeldowitz L.R. Administration of dihydroxyphenylalanine to parkinsonian patients. Can Med Assoc J 90 (1964) 463-466
289. Markey S.P., Johannessen J.N., Chiueh C.C., et al. Intraneuronal generation of a pyrimidium ion metabolite may cause drug-induced parkinsonism. Nature 311 (1984) 464-467
290. Marsden C.D., Obeso J.A., Zarranz J.J., et al. The anatomical basis of symptomatic hemidystonia. Brain 108 (1985) 463-483
291. Martin J.P. Hemichorea resulting from a local lesion of the brain: the syndrome of the body of Luys. Brain 50 (1927) 637-651
292. Martin J.P. Hemichorea (hemiballismus) without lesions in the corpus Luysii. Brain 80 (1957) 1-12
293. Matsumine H., Saito M., Shimoda-Matsubayashi S., et al. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 60 (1997) 588-596
294. Mauriello Jr. J.A. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology 35 (1985) 1499-1500
295. Meige H., and Feindel E. In: Wilson S.A.K. (Ed). Tics and Their Treatment (1907), Sidney Appleton, London 27
296. Mendel G. Versuche über Pflanzenhybriden. Verhandlungen des Naturfarschenden Vereines in Brünn 4 (1865) 3-47
297. Merritt A.D., Conneally P.M., Rahman N.F., et al. Juvenile Huntington's chorea. In: Barbeau A., and Brunette T.R. (Eds). Progress in Neurogenetics (1969), Excerpta Medica Foundation, Amsterdam 645-650
298. Meyers R. Surgical procedure for postencephalitic tremor, with notes on the physiology of premotor fibers. Arch Neurol Psychiatry 44 (1940) 455-459
299. Mink J.W. The basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch Neurol 60 (2003) 1365-1368
300. Mitchell E., and Matthews K.L. Gilles de la Tourette's disease associated with pemoline. Am J Psychiatry 137 (1980) 1617-1619
301. Mitchell I.J., Cross A.J., Sambrook M.A., et al. Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett 61 (1985) 195-200
302. Mitchell K.J. Report of a case of familial tremor of the head. J Nerv Ment Dis 30 (1903) 158-159
303. Mitchell S.W. Post-paralytic chorea. Am J Med Sci 68 (1874) 342-352
304. Molina-Negro P., and Hardy J. Semiology of tremors. Can J Neurol Sci 2 (1975) 23-29
305. Montagu K.A. Catechol compounds in rat tissues and in brains of different animals. Nature 180 (1957) 245-246
306. Myers R.H., Madden J.J., Teague J.L., et al. Factors related to onset age of Huntington disease. Am J Hum Genet 34 (1982) 481-488
307. Narbona J., Obeso J.A., Tunon T., et al. Hemidystonia secondary to localized basal ganglia tumour. J Neurol Neurosurg Psychiatry 47 (1984) 704-709
308. Nausieda P.A., Grossman B.J., Koller W.C., et al. Sydenham chorea: an update. Neurology 30 (1980) 331-334
309. Nutt J.G., Hammerstad J.P., deGarmo P., et al. Cranial dystonia: double-blind crossover study of anticholinergics. Neurology 34 (1984) 215-217
310. Obeso J.A., Rodriquez-Oroz M.C., Rodriguez M., et al. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol 47 (2000) S22-S32
311. O'Brien M.D., Upton A.R., and Toseland P.A. Benign familial tremor treated with primidone. Br Med J 282 (1981) 178-180
312. Olney J.W., and de Gubareff T. Glutamic neurotoxicity and Huntington's chorea. Nature 271 (1978) 557-559
313. Olszewski J., Steele J., and Richardson J.C. Pathological report on six cases of heterogeneous system degeneration. J Neuropathol Exp Neurol 23 (1964) 187-188
314. Oppenheim H. Über eine eigenartige Krampfkrankheit des kindlichen und jegendlichen Alters (Dysbasia lordotica progressiva, Dystonia musculorum deformans). Neurologisches Zentralblatt 30 (1911) 1090-1107
315. Ørbeck A.L. An early description of Huntington's chorea. Med Hist 3 (1959) 165-168
316. Osler W. On the general etiology and symptoms of chorea: based on the records of 410 cases at the Infirmary for Nervous Diseases, Philadelphia. Medical News 51 (1887) 437-441 465-470
317. Osler W. On Chorea and Choreiform Affections (1894), HK Lewis, London
318. Osler W. Historical notes on hereditary chorea. Neurographs 1 (1908) 113-116
319. Ozelius L., Kramer P.L., Moskowitz C.B., et al. Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 2 (1989) 1427-1434
320. Ozelius L.J., Hewett J., Kramer P., et al. Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium. Genome Res 7 (1997) 483-494
321. Ozelius L.J., Hewett J.W., Page C.E., et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 17 (1997) 40-48
322. Pahwa R., Lyons K.L., Wilkinson S.B., et al. Bilateral thalamic stimulation for the treatment of essential tremor. Neurology 53 (1999) 1447-1450
323. Papp M.I., and Lantos P.L. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 107 (1992) 172-182
324. Papp M.I., Kahn J.E., and Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94 (1989) 79-100
325. Parent A. Jules Bernard Luys and the subthalamic nucleus. Mov Disord 17 (2002) 181-185
326. Parkinson J. An Essay on the Shaking Palsy (1817), Whittingham and Rowland, London
327. Penny Jr. J.B., Vonsattel J.P., MacDonald M.E., et al. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41 (1997) 689-692
328. Perutz M.F., Johnson T., Suzuki M., et al. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 91 (1994) 5355-5358
329. Petrukhin K., Fischer S.G., Pirastu M., et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat Genet 5 (1993) 338-343
330. Pettigrew L.C., and Jakovic J. Hemidystonia: a report of 22 patients and a review of the literature. J Neurol Neurosurg Psychiatry 48 (1985) 650-657
331. Piccolomini F. Illustrium Virorum Elogia (1630), Tomasini IP, Florence
332. Poirer L.J., and Sourkes T.L. Influence of the substantia nigra on the catecholamine content of the striatum. Brain 88 (1965) 181-192
333. Polymeropoulos M.H., Higgins J.J., Golbe L.I., et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274 (1996) 1197-1199
334. Polymeropoulos M.H., Lavedan C., Leroy E., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
335. Poore G.V. An analysis of 75 cases of writer's cramp and impaired writing power. Med Chir Trans 61 (1878) 111-146
336. Posey W.C. Paralysis of upward movement of the eyes. Ann Ophthalmol 13 (1904) 523-529
337. Poynton F., and Paine A. Researches on Rheumatism (1913), Churchill Livingstone, London
338. Pramstaller P.P., Schlossmacher M.G., Jaques T.S., et al. Lewy body Parkinson's disease in a large pedigree with 77 parkin mutation carriers. Ann Neurol 58 (2005) 411-422
339. Putnam J.J. A new adjuvant in the treatment of writer's palsy. Boston Medical and Surgical Journal 101 (1879) 320
340. Rabinovitch R. An exaggerated startle reflex resembling a kicking horse. Can Med Assoc J 93 (1965) 130
341. Rammelkamp C.H., Denny F.W., and Wannamaker L.W. Studies on the epidemiology of rheumatic fever in the armed services. In: Thomas L. (Ed). Rheumatic Fever (1952), University of Minnesota Press, Minneapolis, MN 72-89
342. Ranen N.G., Stine O.C., Abbott M.H., et al. Anticipation and instability of IT-15(CAG)n repeats in parent-offspring pairs with Huntington's disease. Am J Hum Genet 57 (1995) 593-602
343. Rebeiz J.J., Kolodny E.H., and Richardson E.P. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc 92 (1967) 23-26
344. Rebeiz J.J., Kolodny E.H., and Richardson Jr. E.P. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18 (1968) 20-33
345. Reid A.H., McCall S., Henry J.M., et al. Experimenting on the past: the enigma of Von Economo's encephalitis lethargica. J Neuropathol Exp Neurol 60 (2001) 663-670
346. Reik W. Genomic imprinting: a possible mechanism for the parental origin effect in Huntington's chorea. J Med Genet 25 (1988) 805-808
347. Reiner A., Albin R.L., Anderson K.D., et al. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85 (1988) 5733-5737
348. Richardson J.C., Steele J., and Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia: a clinical report on eight cases of "heterogeneous system degeneration. Trans Am Neurol Assoc 88 (1963) 25-29
349. Ridley R.M., Frith C.D., Crow T.J., et al. Anticipation in Huntington's disease is inherited through the male line but may originate in the female. J Med Genet 25 (1988) 589-595
350. Ridley R.M., Frith C.D., Farrer L.A., et al. Patterns of inheritance of the symptoms of Huntington's disease suggestive of an effect of genomic imprinting. J Med Genet 28 (1991) 224-231
351. Riley D.E., Lang A.E., Lewis A., et al. Cortical-basal ganglionic degeneration. Neurology 40 (1990) 1203-1212
352. Ristic A., Marinkovic J., Dragaševic N., et al. Long-term prognosis of vascular hemiballismus. Stroke 33 (2002) 2109-2111
353. Robins R.P. The treatment of writers' cramp. Proc Phil Co Med Soc 7 (1885) 271-277
354. Robins R.P. Writers' cramp" and its treatment, with the notes of several cases. Am J Med Sci 89 (1885) 452-462
355. Rodbell M. Signal transduction: evolution of an idea. In: Ringertz N. (Ed). Nobel Lectures, Physiology or Medicine 1991-1995 (1997), World Scientific, Singapore 220-236
356. Roger H. Recherches cliniques sur la chorea, sur le rhumatisme et sur les maladies du Coeur chez les enfants. Archives Générales de Médecine 2 (1866) 641-665
357. Rose I. Ubiquitin at fox chase. In: Frängsmyr T. (Ed). Les Prix Nobel. The Nobel Prizes 2004 (2005), Nobel Foundation, Stockholm 218-225
358. Rothfus W.E., Hirsch W.L., Malatack J.J., et al. Improvement of cerebral CT abnormalities following liver transplantation in a patient with Wilson disease. J Comput Assist Tomogr 12 (1988) 138-140
359. Rubinsztein D.C., Leggo J., Coles R., et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 59 (1996) 16-22
360. Rumpel A. Über das Wesen und die Bedeutung der Leberveränderungen und der Pigmentierungen bei den damit verbunderen Fällen von Pseudosklerose, zugleich ein Beitrag zur Lehre der Pseudosklerose (Westphal-Strumpell). Dtsch Z Nervenheilkd 49 (1913) 54-73
361. Saint-Hilaire M.H., Saint-Hilaire J.M., and Granger L. Jumping Frenchmen of Maine. Neurology 36 (1986) 1269-1271
362. Sano I., Gamo T., Kakimoto Y., et al. Distribution of catechol compounds in human brain. Biochim Biophys Acta 32 (1959) 586-587
363. Scheinberg I.H., and Gitlin D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science 116 (1952) 484-485
364. Scheinberg I.H., and Sternlieb I. Long-term management of hepatolenticular degeneration (Wilson's disease). Am J Med 29 (1960) 316-333
365. Scherer H.J. Beiträge zur pathologischen Anatomie des Kleinhirns. III. Mitteilung: Genuine Kleinhirnatrophien. Z Gesamte Neurol Psychiatr 145 (1933) 335-405
366. Scherer H.J. Extrapyramidale Störungen bei der olivopontocerebellaren Atrophie. Ein Beitrag zum Problem des lokalen vorzeitigen Alterns. Z Gesamte Neurol Psychiatr 145 (1933) 406-419
367. Schiller F. The vicissitudes of the basal ganglia (further landmarks in cerebral nomenclature). Bull Hist Med 41 (1967) 515-538
368. Schiller F. Parkinsonian rigidity: the first hundred-and-one years 1817-1918. Hist Philos Life Sci 8 (1986) 221-236
369. Schiller F. Fritz Lewy and his bodies. J Hist Neurosci 9 (2000) 148-151
370. Schonecker M. Ein eigentumliches Syndrom im oralen Bereich bei Megaphen Applikation. Nervenarzt 28 (1957) 35-36
371. Schouwink G. De Hepato-cerebrale Degeneratie: Met een Onderzoek van de Zinkstofwisseling (1961), MD thesis (with a summary in English, French, and German), University of Amsterdam, Amsterdam
372. Schuurman P.R., Bosch D.A., Bossuyt P.M.M., et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342 (2000) 461-468
373. Schwab R.S., Amador L.V., and Levine J.Y. Apomorphine in Parkinson's disease. Trans Am Neurol Assoc 76 (1951) 273-279
374. Schwalbe M.W. Eine eigentümliche tonische Krampfform mit hysterischen Symptomen: Medizin und Chirurgie (1908), Universitäts-Buch-druckerei G. Schade, Berlin
375. Scott A.B., Rosenbaum A., and Collins C.C. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol Vis Sci 12 (1973) 924-927
376. Sée G. De la choreé. Mémoires de l'Académie Royale de Médecine (Paris) 15 (1850) 374
377. Seignot M.J.N. A case of the syndrome of tics of Gilles de la Tourette controlled by R 1625. Ann Med Psychol 28 (1961) 92-97
378. Shahani B.T., and Young R.R. Physiological and pharmacological aids in the differential diagnosis of tremor. J Neurol Neurosurg Psychiatry 39 (1976) 772-783
379. Shahzadi S., Tasker R.R., and Lozano A. Thalamotomy for essential and cerebellar tremor. Stereotact Funct Neurosurg 565 (1995) 11-17
380. Shapiro A.K., Shapira E., and Wayne H. Treatment of Tourette's syndrome: with haloperidol, review of 34 cases. Arch Gen Psychiatry 28 (1973) 92-97
381. Sharp F.R., Rando T.A., Greenberg S.A., et al. Pseudochoreoathetosis: movements associated with loss of proprioception. Arch Neurol 41 (1994) 1103-1109
382. Sheehy M.P., and Marsden C.D. Writer's cramp - a focal dystonia. Brain 105 (1982) 461-480
383. 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5 (1993) 351-358
384. Shimura H., Hattori N., Kubo S., et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25 (2000) 302-305
385. Shimura H., Schlossmacher M.G., Hattori N., et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293 (2001) 263-269
386. Shy G.M., and Drager G.A. A neurologic syndrome associated with orthostatic hypotension. Arch Neurol 2 (1960) 511-527
387. Sider D., and McVaugh M. Galen on tremor, palpitation, spasm, and rigor: Galeni De tremore, palpitatione, convulsione, et rigore. Trans Stud Coll Physicians Phila 1 (1979) 183-210
388. Siderowf A.D., Galetta S.L., Hurtig H.I., et al. Posey and Spiller and progressive supranuclear palsy: an incorrect attribution. Mov Disord 13 (1998) 170-174
389. Siegfried J. Chronic electrical stimulation of the VL-VPL complex and of the pallidum in the treatment of extrapyramidal and cerebellar disorders. Personal experience since 1985. Stereotact Funct Neurosurg 62 (1994) 71-75
390. Siegfried J., and Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35 (1994) 1126-1129
391. Siemerling E., and Oloff H. Pseudosklerose (Westphal-Strumpell) mit Cornealring (Kayser-Fleischer) unter doppelseitiger Scheinkatarakt, die nur bei Seitlicherbeleuchtung sichtbar ist und die, der nach Verletzung durch kupfersplitterentstehenden Katarakt ähnlich ist. Klin Wochenschr 1 (1922) 1087-1089
392. Simpson D.M., Blitzer A., Brashear A., et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 (2008) 1699-1706
393. Singer H.S., Butler I.K., Tune L.E., et al. Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 12 (1982) 361-366
394. Sinkler W. Choreiform affections. In: Dercum F.X. (Ed). A Text-book on Nervous Diseases by American Authors (1895), Lea Brothers and Co., Philadelphia, PA 227-269
395. Slavin K.V., Baumann T.K., and Burchiel K.J. Treatment of hemiballismus with stereotacticc pallidotomy. Case report and review of the literature. Neurosurg Focus 17 (2004) E7
396. Smith Y., and Parent A. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res 453 (1988) 353-356
397. Snell R.G., MacMillan J.C., Cheadle J.P., et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 4 (1993) 393-397
398. Sokol R.J., Francis P.D., Gold S.H., et al. Orthotopic liver transplantation for acute fulminant Wilson disease. J Pediatr 107 (1985) 549-552
399. Solly S. Clinical lectures on scriveners' palsy, or the paralysis of writers: Lecture I. Lancet ii (1864) 709-711
400. Solly S. Clinical lectures on scriveners' palsy, or the paralysis of writers: Lecture II. Lancet i (1865) 84-86
401. Solly S. Clinical lectures on scriveners' palsy, or the paralysis of writers: Lecture III. Lancet i (1865) 113-115
402. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. JAMA 268 (1992) 2069-2073 (Correction 1993; 269: 476)
403. Speelman J.D., and Bosch D.A. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord 13 (1998) 582-588
404. Spiegel E.A., Wycis H.T., Marks M., et al. Stereotaxic apparatus for operations on the human brain. Science 106 (1947) 349-350
405. Spillantini M.G., Schmidt M.L., Lee V.-Y., et al. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
406. Spillantini M.G., Crowther R.A., Jakes R., et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251 (1998) 205-208
407. Spiller W.G. The importance in clinical diagnosis of paralysis of associative movement of the eyeballs (Blick-Lahmung) especially of upward and downward associated movements. J Nerv Ment Dis 32 (1905) 417-488 497-530
408. Squitieri F., Gellera C., Cannella M., et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126 (2003) 946-955
409. Steck H. Le syndrome extrapyramidal et diencephalique au cours des traitments au largactil et au serpasil. Ann Med Psychol (Paris) 112 (1954) 737-743
410. Steele J.C. Progressive supranuclear palsy. Brain 95 (1972) 693-704
411. Steele J.C. Historical notes. J Neural Transm Suppl 42 (1994) 3-14
412. Steele J.C., Richardson J.C., and Olszewski J. Progressive supranuclear palsy. Arch Neurol 10 (1964) 333-359
413. Stine O.C., Pleasant N., Franz M.L., et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Molec Genet 2 (1993) 1547-1549
414. Stollerman G.H. Changing streptococci and prospects for the global eradication of rheumatic fever. Perspect Biol Med 40 (1997) 165-189
415. Suarez J.I., Metman L.V., Reich S.G., et al. Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Ann Neurol 42 (1997) 807-811
416. Suhren O., Bruyn G.W., and Tuynman J.A. Hyperexplexia: a hereditary startle syndrome. J Neurol Sci 3 (1966) 577-605
417. Sweeney P.J., Lloyd M.F., and Daroff R.B. What's in a name? Dr. Lewey and the Lewy body. Neurology 49 (1997) 629-630
418. Sydenham T. Schedula Monitoria de Novae Febris Ingressu (1686), G Kettilby, London
419. Sydenham T. On St. Vitus's dance. In: Latham R.G. (Ed). The Entire Works of Thomas Sydenham. Vol. 2 (1848/1979), Sydenham Society, London 257-259 [Reprinted in 1979 by The Classics in Medicine Society, Birmingham, AL.]
420. Tanzi R.E., Petrukhin K., Chernov I., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5 (1993) 344-350
421. Taranta A., and Stollerman G.H. The relationship of Sydenham's chorea to infection with Group A streptococci. Am J Med 20 (1956) 170-175
422. n repeats length is the sex of affected parents. Hum Mol Genet 2 (1993) 1535-1540
423. Telenius H., Kremer B., Goldberg Y.P., et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet 6 (1994) 409-414
424. n changes in Huntington disease. Hum Mol Genet 4 (1995) 189-195
425. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol 50 (1993) 1013-1016
426. Tiemann G. American Armamentarium Chirurgicum (1899), George Tiemann and Co., New York 712-713 [Reprint edition, published by Jeremy Norman and Co. Inc., Novato, CA, 1989.]
427. Todd E.W. Antigenic streptococcal hemolysin. J Exp Med 55 (1932) 267-280
428. Tomonaga M. Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (Berl) 37 (1977) 1771-1781
429. Trétiakoff C. Contribution à l'étude de l'anatomie pathologique du Locus Niger de Soemmerring avec quelques déductions relatives à la pathogénie des troubles du tonus musculaire et de la maladie de Parkinson. Thèse, Faculté de Médecine (1919), Université de Paris, Paris
430. Trétiakoff C. Contribution à l'étude de l'anatomie du locus niger. Rev Neurol (Paris) 28 (1921) 592-600
431. Trottier Y., Biancalana V., and Mandel J.L. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet 31 (1994) 377-382
432. Truong D.D., and Fahn S. An early description of dystonia: translation of Schwalbe's thesis and information on his life. Adv Neurol 50 (1988) 651-654
433. Tschermak von Seysenegg E. Über künstliche Kreuzung bei Pisum sativum. Zeitschrift für das Landwirthschaftliche Versuchswesen in Oesterreich 3 (1900) 465-555
434. Tsui J.K., Eisen A., Mak E., et al. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 12 (1985) 314-316
435. Tsui J.K., Eisen A., Stoessl A.J., et al. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 2 (1986) 245-247
436. Tsui J.K., Fross R.D., Calne S., et al. Local treatment of spasmodic torticollis with botulinum toxin. Can J Neurol Sci 14 (1987) 533-535
437. Tu P.H., Galvin J.E., Baba M., et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 44 (1998) 415-422
438. Ueda K., Fukushima H., Masliah E., et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 11282-11286
439. Uhrbrand L., and Faurbye A. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, and electroconvulsive therapy. Psychopharmacologia 1 (1960) 408-418
440. Unverricht H. Die Myoklonie (1891), Franz Deutike, Leipzig
441. Uzman L.L., Iber F.L., Chalmers T.C., et al. The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease). Am J Med Sci 231 (1956) 511-518
442. Van Putten T. The many faces of akathisia. Compr Psychiatry 16 (1975) 43-47
443. Vesalius A. De Humani Corporis Fabrica. J Oporini, Basel (1542)
444. Vidailhet M., Vercueil L., Houeto J.L., et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 352 (2005) 459-467
445. Vilensky J.A., Robertson W.M., and Gilman S. Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]). Neurology 59 (2002) 914-916
446. Vogt A. Kupfer und Silber aufgespeichert in Auge, Leber, Milz und Nieren als Symptom der Pseudosklerose. Klin Monatsbl Augenheilkd 83 (1929) 417-419
447. Vogt O., and Vogt C. Zur Lehre der Erkrankungen des striaren Systeme. Journal für Psychologie und Neurologie 25 (1920) 627-846
448. von Economo C. Encephalitis Lethargica. Wien Klin Wochenschr 30 (1917) 581-583
449. von Economo C. Die Encephalitis Lethargica (1918), Franz Deuticke, Leipzig and Vienna
450. von Economo C. Die Encephalitis Lethargica, ihre Nachkrankheiten und ihre Behandlung (1929), Urban und Schwartzenberg, Berlin
451. von Economo C. In: Newman K.O. (Ed). Encephalitis Lethargica: Its Sequelae and Treatment (1931), Oxford University Press, London Translated by
452. von Strümpel A. Über die Westphal'sche Pseudosklerose und über diffuse Hirnsklerose insbesondere bei Kindern. Dtsch Z Nervenheilkd 12 (1898) 115-149
453. Vonsattel J.P., Myers R.H., Stevens T.J., et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44 (1985) 559-577
454. Wakabayashi K., Yoshimoto M., Tsuji S., et al. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249 (1998) 180-182
455. Walshe F.M.R. On the symptom complexes of lethargic encephalitis with special reference to the involuntary muscular contractions. Brain 43 (1920) 197-219
456. Walshe J.M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med 21 (1956) 487-495
457. Walshe J.M. The treatment of Wilson's disease with penicillamine. Lancet 1 (1960) 188-192
458. Walshe J.M. Wilson's disease: the presenting symptoms. Arch Dis Child 37 (1962) 253-256
459. Walshe J.M. Toxic reactions to penicillamine in patients with Wilson's disease. Postgrad Med J (Suppl) (1968) 6-8
460. Walshe J.M. Treatment of Wilson's disease with trientine (triethylene tetramine) dichloride. Lancet 1 (1982) 643-647
461. Walshe J.M. The story of penicillamine: a difficult birth. Mov Disord 18 (2003) 853-859
462. Walshe J.M. History of Wilson's disease: 1912 to 2000. Mov Disord 21 (2006) 142-147
463. Wasmuth J.J., Hewitt J., Smith B., et al. A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature 332 (1988) 734-736
464. Waters C.O. In: Dunglison R. (Ed). The Practice of Medicine, or a Treatise on Special Pathology and Therapeutics (1842), Lea and Blanchard, Philadelphia, PA 312 Vol. 2
465. West W.J. On a peculiar form of infantile convulsions. Lancet i (1861) 724-725
466. Westphal C. Über eine dem Bilde der cerebrospinalen grauen Degeneration ähnliche Erkrankung des centralen Nervensystems ohne anatomischen Befund, nebst einigen Bemerkungen über paradoxe Contraktion. Arch Psychiatr Nervenkr 14 (1883) 87-134
467. Wexler N.S., Young A.B., Tanzi R.E., et al. Homozygotes for Huntington's disease. Nature 326 (1987) 194-197
468. Whittier J.R. Ballism and subthalamic nucleus (nucleus hypothalamicus; corpus Luysi). Review of the literature and study of thirty cases. Arch Neurol Psychiatry 58 (1947) 672-692
469. Whittier J.R., and Mettler F.A. Studies on the subthalamus of the rhesus monkey. I. Anatomy and fiber connections of the subthalamic nucleus of Luys. J Comp Neurol 90 (1949) 281-314
470. Whittier J.R., and Mettler F.A. Studies on the subthalamus of the rhesus monkey. II. Hyperkinesia and other physiologic effects of subthalamic lesions, with special reference to the subthalamic nucleus of Luys. J Comp Neurol 90 (1949) 319-372
471. Wichmann T., and DeLong M.R. Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg Clin N Am 9 (1998) 223-236
472. Willis T. The London Practice of Physick: Or the Whole Practical Part of Physick Contained in the Works of Dr. Willis. Faithfully Made English, and Printed Together for the Publick Good (1685), Thomas Basset, London 413
473. Wilson S.A.K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver (1911), Thesis, University of Edinburgh, Edinburgh
474. Wilson S.A.K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 34 (1912) 295-509 [Excerpts of this paper were reprinted in Arch Neurol 1971; 25: 180-186.]
475. Wilson S.A.K. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Lancet 1 (1912) 1115-1119
476. Wilson S.A.K. Dégénération lenticulaire progressive: maladie familiale associée à la cirrhose du foie. Rev Neurol (Paris) 23 (1912) 229-233
477. Wilson S.A.K. Progressive Degeneration des Linsenkerns. In: Lewandowsky M. (Ed). Handbuch der Neurologie (1914), Springer, Berlin 950-990 Vol. 5
478. Wilson S.A.K. Disorders of motility and muscle tone with special reference to the corpus striatum (Croonian Lectures). Lancet 2 (1925) 215-291
479. Winkler G.F., and Young R.R. Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N Engl J Med 290 (1974) 984-988
480. Winslow R.S., Stillner V., Coons D.J., et al. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics. Am J Psychiatry 143 (1986) 706-710
481. Yahr M.D., Duvoisin R.C., Schear M.J., et al. Treatment of parkinsonism with levodopa. Arch Neurol 21 (1969) 343-354
482. Yang W., Dunlap J.R., Andrews R.B., et al. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Molec Genet 11 (2002) 2905-2917
483. Yoon S.-R., Dubeau L., de Young M., et al. Huntington disease expansion mutations in humans can occur before meiosis is completed. Proc Natl Acad Sci USA 100 (2003) 8834-8838
484. Young R.R., and Shahani B.T. Asterixis: one type of negative myoclonus. Adv Neurol 43 (1986) 137-156
485. Young R.R., Shahani B.T., and Kjellberg R.J. Unilateral asterixis produced by a discrete CNS lesion. Trans Am Neurol Assoc 101 (1976) 306-307
486. Zabel B.U., Naylor S.L., Sakaguchi A.Y., et al. Mapping of the DNA locus D4S10 and the linked Huntington's disease gene to 4p16-p15. Cytogenet Cell Genet 42 (1986) 187-190
487. Zeman W. Pathology of the torsion dystonias (dystonia musculorum deformans). Neurology 20 (1970) 79-88
488. Zeman W., and Dyken P. Dystonia musculorum deformans: clinical, genetic and pathoanatomical studies. Psychiatr Neurol Neurochir 70 (1967) 77-121
489. Zeman W., Kaelbling R., and Pasamanick B. Idiopathic dystonia musculorum deformans. I. The hereditary pattern. Am J Hum Genet 11 (1959) 188-202
490. Zeman W., Kaelbling R., and Pasamanick B. Idiopathic dystonia musculorum deformans. II. The formes frustes. Neurology 10 (1960) 1068-1075
491. Zesiewicz T.A., Elbe R., Louis E.D., et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 64 (2005) 2008-2020
492. Ziehen T. Ein Fall von tonischer Torsionsneurose. Neurologisches Zentralblatt 30 (1911) 109-110
493. Zoghbi H.Y., and Orr H.T. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23 (2000) 217-247
494. n repeat in the Huntington disease gene. Hum Molec Genet 2 (1993) 2063-2067